3 ‘Strong Buy’ Stocks to Buy in Today’s Volatile Market, 2/23/2026, According to Top Analysts

FomoAnxiety · 2026-02-24T05:44:16+00:00

Top Wall Street analysts recommend three stocks as Strong Buys: Spyre Therapeutics, Nvidia, and Robinhood, each showing significant potential upside in their 12-month targets.

FomoAnxiety

2026-02-24 05:44:16

Abstract generation in progress

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.

Claim 50% Off TipRanks Premium

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts.

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

Spyre Therapeutics (SYRE) – Spyre Therapeutics is a biotech firm making antibody drugs for bowel diseases such as ulcerative colitis and Crohn’s disease. Today, TD Cowen analyst Tyler Van Buren maintained a Buy rating on the stock. In the last three months, all five Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 40%.

Nvidia (NVDA) – Nvidia is a chip company that designs GPUs and AI processors used in data centers, gaming PCs, and cloud computing**.** Today, Wedbush analyst Daniel Ives maintained a Buy rating on the stock with a $250 price target. In the last three months, all 30 Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 39.9%.

**Robinhood **(HOOD) – Robinhood is an online brokerage platform that lets users trade stocks, options, and crypto through a mobile app. Today, Barclays analyst Benjamin Budish maintained a Buy rating on the stock with a $124 price target. Interestingly, 11 out of the 13 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 72.12%.

Who Are the Top Analysts?

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time.

Disclaimer & DisclosureReport an Issue

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.